Dipeptidyl peptidase-4 is increased in the abdominal aortic aneurysm vessel wall and is associated with aneurysm disease processes

BACKGROUND: Abdominal aortic aneurysm (AAA) is a potentially life-threatening disease, and until today there is no other treatment available than surgical intervention. Dipeptidyl peptidase-4 (DPP4)-inhibitors, used clinically to treat type 2 diabetes, have in murine models been shown to attenuate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindquist Liljeqvist, Moritz, Eriksson, Linnea, Villard, Christina, Lengquist, Mariette, Kronqvist, Malin, Hultgren, Rebecka, Roy, Joy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977716/
https://www.ncbi.nlm.nih.gov/pubmed/31971988
http://dx.doi.org/10.1371/journal.pone.0227889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977716/
https://www.ncbi.nlm.nih.gov/pubmed/31971988
http://dx.doi.org/10.1371/journal.pone.0227889

Ejemplares similares